Abstract
In 2007, the United States Pharmacopeia finalized a program to ensure that compounded sterile products prepared for individual patients by physician order were indeed prepared aseptically. The program name became the chapter number in the national formulary, i.e., 〈797〉. Accredited clinical or environmental laboratories are required to support microbial testing of (i) the air in the i.v. area and hoods, (ii) the sterility of the compounded product itself, (iii) the reliability of surface decontamination, and (iv) the determination of whether the pharmacist or pharmacy technician can compound a surrogate product aseptically. This article reviews those quality metrics for pharmacies that involve microbial testing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
